Sign in to view content

The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease

Jeffrey S. Heier, MD

Video
Published 2016

Related

Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Annual Meeting Talks
2023
Phase 2 Study of Two Formulations of AR-1105 in Macular Edema (ME) Secondary to Retinal Vein Occlusion (RVO)
Michael A. Singer, MD
Annual Meeting Talks
2021

Category: Retinal Vascular Disease

See more